Asston Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	244.84	250.39	155.86	65.38	95.99	80.34
Revenue Growth (YoY)	274.49%	60.65%	138.39%	-31.89%	19.47%	221.60%
Cost of Revenue	132.52	141.44	97.54	33.49	76.74	53.12
Gross Profit	112.33	108.96	58.32	31.89	19.25	27.22
Selling, General & Admin	16.34	15.02	8.81	5.93	6.18	5.47
Other Operating Expenses	32.33	29.98	16.61	10.79	16.62	19.15
Operating Expenses	49.98	45.81	25.92	17.09	22.89	24.79
Operating Income	62.35	63.14	32.4	14.8	-3.64	2.43
Interest Expense	-6.54	-7.98	-9.01	-6.76	-4.25	-0.81
Interest & Investment Income	0.87	0.87	1.21	0.51	0	-
Currency Exchange Gain (Loss)	-2.36	-2.36	-7.45	5.11	7.45	-0.01
Other Non Operating Income (Expenses)	11.82	3.32	1.02	0.47	2.02	-0.41
Pretax Income	32.65	57	18.17	14.13	1.59	1.21
Income Tax Expense	8.07	13.75	4.57	3.56	0.48	0.3
Net Income	24.58	43.25	13.6	10.57	1.11	0.92
Net Income to Common	24.58	43.25	13.6	10.57	1.11	0.92
Net Income Growth	132.63%	217.95%	28.74%	855.34%	20.70%	160.49%
Shares Outstanding (Basic)	7	6	6	6	0	0
Shares Outstanding (Diluted)	7	6	6	6	0	0
Shares Change (YoY)	16.68%	11.99%	-	5783.59%	18.98%	-
EPS (Basic)	3.76	6.90	2.43	1.89	11.63	11.45
EPS (Diluted)	3.76	6.90	2.37	1.89	11.62	11.45
EPS Growth	99.37%	191.00%	25.61%	-83.76%	1.45%	160.49%
Free Cash Flow	-	-1.63	-38.11	-5.67	-11.89	-16.62
Free Cash Flow Per Share	-	-0.26	-6.80	-1.01	-124.88	-207.77
Gross Margin	45.88%	43.51%	37.42%	48.77%	20.05%	33.88%
Operating Margin	25.46%	25.22%	20.79%	22.63%	-3.79%	3.03%
Profit Margin	10.04%	17.27%	8.73%	16.16%	1.15%	1.14%
Free Cash Flow Margin	-	-0.65%	-24.45%	-8.67%	-12.38%	-20.69%
EBITDA	63.6	63.95	32.9	15.17	-3.55	2.6
EBITDA Margin	25.97%	25.54%	21.11%	23.20%	-3.70%	3.24%
D&A For EBITDA	1.25	0.81	0.51	0.37	0.08	0.17
EBIT	62.35	63.14	32.4	14.8	-3.64	2.43
EBIT Margin	25.46%	25.22%	20.79%	22.63%	-3.79%	3.03%
Effective Tax Rate	24.72%	24.12%	25.14%	25.20%	30.40%	24.56%
Revenue as Reported	259.05	256.1	158.41	71.92	105.55	81.26
Advertising Expenses	-	-	-	-	-	0.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.